Proton Pump Inhibitors (PPIs) Market Driven by Strong Pipeline and Rising Approvals, projected to Reach USD 5.6 Billion by 2034 | TMR


Growth in product launches by key players is expected to fuel the overall proton pump inhibitors (PPIs) market value during the forecast period.

Wilmington, Delaware, United States, Transparency Market Research. Inc. , July 08, 2024 (GLOBE NEWSWIRE) — The global proton pump inhibitors (PPIs) market (inhibidores de la bomba de protons) stood at US$ 3.7 billion in 2023, and the global market is projected to reach US$ 5.6 billion in 2034. The Proton Pump Inhibitors (PPIs) market is anticipated to expand at a CAGR of 4% between 2024 and 2034.

Proton pump inhibitors (PPIs), introduced over 25 years ago, have proven highly effective and safe for treating a range of acid-related conditions. They are the preferred first-line treatment for gastroesophageal reflux disease (GERD), providing short-term relief and long-term prevention of recurrence by reducing stomach acid secretion. Available both over the counter and by prescription, medications like omeprazole, lansoprazole, and esomeprazole effectively manage persistent heartburn associated with GERD.


The PPI market is poised for growth with increased releases of new products by major companies, expected to bolster market value in the coming years. Innovations such as delayed-release capsules and liquid formulations cater to patients who struggle with swallowing solid forms, driving market expansion. Key players’ robust pipelines and ongoing product approvals for new GERD and ulcer treatments further anticipate significant market growth in the forecast period.

Request for Sample PDF copy of report:

The proton pump inhibitors (PPIs) market is witnessing significant growth driven by the increasing prevalence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. PPIs, which include drugs like omeprazole, esomeprazole, and pantoprazole, are highly effective in reducing stomach acid production by inhibiting the enzyme system of gastric proton pumps. This class of drugs is preferred for its efficacy in providing long-term relief from acid-related disorders.

Several factors contribute to the expanding PPI market. The rise in the aging population, which is more prone to acid-related gastrointestinal conditions, plays a crucial role. Additionally, lifestyle changes, including increased consumption of fast food, alcohol, and smoking, have led to a higher incidence of GERD and other related conditions, further driving the demand for PPIs. The availability of over-the-counter (OTC) PPIs has also made these medications more accessible to the general public, boosting market growth.

Pharmaceutical companies are actively engaged in research and development to enhance the efficacy and safety profiles of PPIs. Innovations such as combination therapies, which pair PPIs with other drugs to improve treatment outcomes, are becoming more common. Moreover, the market is witnessing a trend towards the development of novel PPIs with improved pharmacokinetic properties, such as faster onset of action and longer duration of effect.

However, the PPI market faces challenges, including the emergence of side effects associated with long-term use, such as an increased risk of kidney disease, bone fractures, and vitamin B12 deficiency. These concerns have led to a growing emphasis on appropriate prescribing practices and the exploration of alternative therapies. Geographically, North America dominates the PPI market due to the high prevalence of gastrointestinal disorders and strong healthcare infrastructure.

Top of Form

Key Takeaways of 양성자 펌프 억제제 Market Report

  • Global proton pump inhibitors (PPIs) market to generate absolute dollar opportunity worth US$ 5.6 billion until 2034.
  • Global proton pump inhibitors (PPIs) market is valued at US$ 3.7 billion in 2023.
  • North America is forecasted to hold the largest share in 2023.

Proton Pump Inhibitors (PPIs) Market: Growth Drivers

  • The global increase in gastrointestinal disorders is attributed to poor dietary choices, sedentary lifestyles, stress, and an aging population. Diets high in fat, spice, and acidity, coupled with irregular eating patterns, often lead to acid reflux and digestive issues.
  • The surge in disorders has prompted heightened product approvals and a robust pipeline of new Proton Pump Inhibitor (PPI) drugs targeting GERD and ulcers.
  • Key players in the PPI sector are actively developing these treatments, which is expected to drive overall market growth during the forecast period. As a result, the PPI market is poised for significant expansion, addressing the rising demand for effective acid-reducing medications and improving gastrointestinal health globally.

Unlock Growth Potential in Your Industry! Download PDF Brochure:

Proton Pump Inhibitors (PPIs) Market: Regional Landscape

  • North America maintains dominance in the Proton Pump Inhibitors (PPIs) market, propelled by advanced healthcare expenditure and well-established clinics and hospitals equipped with modern diagnostic and treatment options.
  • Within this region, the omeprazole and pantoprazole segments lead the PPI market, fueled by the increasing number of visits to physician offices for acid reflux diseases like GERD and peptic ulcers.
  • The drugs are favored for their efficacy in managing such conditions, contributing significantly to market dynamics. With North America’s robust healthcare infrastructure and rising prevalence of gastrointestinal disorders, the demand for PPIs is expected to continue growing, reinforcing the region’s prominent position in the global PPI market.
  • Top of Form

Proton Pump Inhibitors (PPIs) Market: Key Players

  • In 2023, Zydus Cadila launched a novel formulation of pantoprazole, a widely used PPI, with improved bioavailability and longer duration of action. This innovation aims to enhance treatment outcomes for patients with acid-related gastrointestinal disorders such as GERD and peptic ulcers, offering increased convenience and effectiveness.
  • In 2023, Sun Pharmaceutical Industries Ltd. introduced a new generic version of esomeprazole, expanding its portfolio of PPI medications. This addition provides healthcare providers and patients with a more affordable alternative for managing acid reflux diseases, further contributing to the accessibility and availability of essential medications in the PPI market.

Proton Pump Inhibitors (PPIs) Market: Segmentation

Drug Type

  • Omeprazole
  • Pantoprazole
  • Esomeprazole
  • Lansoprazole
  • Rabeprazole
  • Others (Dexlansoprazole, etc.)

Indication Type

  • Gastroesophageal Reflux Disease
  • Peptic Ulcers

End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies


  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Get this Insightful Premium Research Report:

More Trending Reports by Transparency Market Research –

  • Point-of-Care Glucose Testing MarketThe global Markt für Point-of-Care-Glukosetests is projected to flourish at a CAGR of 4.3% from 2022 to 2032. A valuation of US$ 5.8 billion is anticipated for the market in 2032. As of 2023, the market for point-of-care glucose testing is expected to close at US$4.0 billion.
  • Dental Implant Motors MarketThe global 歯科インプラントモーター市場 is expected to grow at a CAGR of 3.5% during the forecast period from 2021 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research Inc.


1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453


Email: [email protected]

Follow Us: LinkedIn| Twitter| Blog | YouTube

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.